TY - JOUR
TI - Cochlear implants: 100 Pediatric case conversions from the body worn to the Nucleus Esprit 22 ear level speech processor
AU - Dodd, M.C.
AU - Nikolopoulos, T.P.
AU - Totten, C.
AU - Cope, Y.
AU - O'Donoghue, G.M.
JO - Otology and Neurotology
PY - 2005
VL - 26
TODO - 4
SP - 635-638
PB - 
SN - null
TODO - 10.1097/01.mao.0000178147.91139.75
TODO - article;  child;  cochlea prosthesis;  controlled study;  conversation;  electrode;  feasibility study;  female;  human;  major clinical study;  male;  pediatrics;  priority journal;  rank sum test;  signal noise ratio;  skin flap;  speech discrimination;  speech perception;  statistical significance;  Student t test;  treatment outcome;  United Kingdom;  Wilcoxon signed ranks test, Child;  Child, Preschool;  Cochlear Implants;  Deafness;  Equipment Design;  Female;  Humans;  Infant;  Male;  Reoperation;  Speech Perception
TODO - Objective: To assess performance of Nucleus 22 mini system pediatric users converted from the Spectra 22 body-worn to the ESPrit 22 ear-level speech processor using aided thresholds and speech discrimination measures before and after the conversion. Study Design: Spectra 22 body-worn speech processor users were chosen using preselection criteria (stable map, ability to report on the quality of the signal, no device problems). The subjects underwent tuning, map conversion, fitting of the ESPrit 22, and aided soundfield threshold and speech discrimination testing. Subjects: The first 100 consecutive conversions are analyzed in this study. Fifty children (50%) were female, and 50 (50%) were male. The average age at implantation was 4.6 years (median 4.3 years, range 1.7 to 11 years). The average age of fitting the ear level speech processor was 11.1 years (median 11 years, range 6.2 to 18.2 years). Setting: Tertiary referral pediatric cochlear implant center in the United Kingdom. Results: Of the 100 fittings attempted, all Spectra 22 maps could to be converted for use in the ESPrit 22. Of these 100 fittings, 44 were straightforward with no adjustment to map parameters being required, and 56 needed rate reductions and other map adjustments to achieve the conversion. The difference of the mean thresholds before and after the conversion did not exceed 2 dB across the frequencies studied (0.5-4 kHz). In 95% of the cases, the differences were less than 9 dB(A). With regard to speech discrimination testing, the mean threshold before the conversion was 53.4 dB and after the conversion 52.7 dB. Of the 100 conversions, only five children stopped using the ESPrit 22 despite fitting being achieved. Conclusion: Conversion from the Spectra 22 body worn to the ESPrit 22 ear level speech processor was found to be feasible in all the 100 cases studied. Only a minority (5%) of children chose not to use the ear level speech processor suggesting that children and parents were satisfied from the conversion. © 2005, Otology & Neurotology, Inc.
ER -